The chemical class of "Vmn1r13 Inhibitors" encompasses a range of compounds, each characterized by its potential to influence cellular mechanisms or pathways that might indirectly affect the activity or expression of the Vmn1r13 protein. Vmn1r13, encoded by the Vmn1r13 gene, is involved in various cellular processes, although its precise biological functions and interactions within the cell are not completely understood. The inhibitors and activators listed do not interact directly with Vmn1r13 but target different signaling pathways and cellular processes that might modulate its function or expression.
Compounds such as LY294002 and Rapamycin, which inhibit the PI3K and mTOR pathways respectively, could modulate cell survival and growth processes, potentially affecting Vmn1r13's role in these pathways. Staurosporine, a kinase inhibitor, Forskolin, which increases cAMP levels, and Trichostatin A, a histone deacetylase inhibitor, can alter various signaling pathways and gene expression patterns, potentially influencing Vmn1r13's regulation or activity.
5-Azacytidine, a DNA methyltransferase inhibitor, might impact DNA methylation and gene expression, potentially affecting genes related to Vmn1r13. SB431542, a TGF-beta receptor inhibitor, and Y-27632, a Rho kinase inhibitor, could influence specific cellular processes and pathways related to Vmn1r13's function.
Bortezomib, a proteasome inhibitor, and Curcumin, known for modulating multiple signaling pathways, can influence protein stability and multiple signaling pathways, respectively, potentially including those involving Vmn1r13. PD98059, a MEK inhibitor, and Cycloheximide, an inhibitor of protein synthesis, could potentially impact signaling pathways and protein expression patterns related to Vmn1r13.
This class of inhibitors is characterized by its indirect mode of action, targeting various signaling cascades and cellular processes to potentially influence the activity or expression of Vmn1r13. Each compound has distinct pharmacological properties and modes of action, reflecting the complexity of cellular signaling networks and the multifaceted nature of protein regulation within these networks. The diversity in this chemical class underscores the broad spectrum of molecular interactions and pathways that can be modulated to affect a specific protein's activity, such as Vmn1r13, in complex biological systems.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
PI3K inhibitor, could impact cell survival and growth pathways, potentially affecting Vmn1r13. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR inhibitor, might influence autophagy and growth pathways potentially linked to Vmn1r13. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Kinase inhibitor, may affect multiple signaling pathways related to Vmn1r13. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Activates adenylyl cyclase, increasing cAMP levels, possibly influencing pathways involving Vmn1r13. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Histone deacetylase inhibitor, could alter gene expression potentially impacting Vmn1r13. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor, might affect DNA methylation patterns linked to Vmn1r13. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
TGF-beta receptor inhibitor, potentially impacting signaling pathways related to Vmn1r13. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Rho kinase inhibitor, can affect cytoskeleton organization, potentially influencing Vmn1r13-related paths. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Proteasome inhibitor, can affect protein degradation, potentially influencing Vmn1r13 stability. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Modulates multiple signaling pathways, potentially influencing Vmn1r13 activity. | ||||||